Provided by Tiger Trade Technology Pte. Ltd.

Loews

109.08
+0.40000.37%
Post-market: 109.080.00000.00%16:10 EDT
Volume:611.77K
Turnover:66.58M
Market Cap:22.30B
PE:13.37
High:109.69
Open:109.51
Low:108.14
Close:108.68
52wk High:121.01
52wk Low:95.71
Shares:204.43M
Float Shares:164.40M
Volume Ratio:0.75
T/O Rate:0.37%
Dividend:0.25
Dividend Rate:0.23%
EPS(TTM):8.16
EPS(LYR):7.97
ROE:9.31%
ROA:1.91%
PB:1.17
PE(LYR):13.68

Loading ...

Loews (L) Stock After 5-Year 102% Return Is The Current Price Justified

Simply Wall St.
·
Jun 16

Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

GlobeNewswire
·
Jun 11

Southwest Securities: Post-PD-(L)1 Treatment Resistance Poses Significant Challenge, 2026 to See High Concentration of Catalysts

Stock News
·
Jun 11

Loews Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 11

Loews sets final BDR dividend at BRL 0.22 per share

Reuters
·
Jun 11

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

GlobeNewswire
·
Jun 10

Token Economy: Redefining the Production Function from Knowledge Acquisition to Real-World Application

Deep News
·
Jun 04

New Trump administration tariffs, this time on forced labor, could come into force as existing ones roll off

Dow Jones
·
Jun 03

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

GlobeNewswire
·
Jun 02

Loews director Dino Robusto acquires $523,700 common shares

Reuters
·
Jun 01

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

GlobeNewswire
·
Jun 01

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

GlobeNewswire
·
May 31

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

GlobeNewswire
·
May 31

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

GlobeNewswire
·
May 31

What Makes ImmuNotion Stand Out in the Eyes of Global Pharmaceutical Giants?

Deep News
·
May 29

Loews Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 28

Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC

GlobeNewswire
·
May 27

BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting

GlobeNewswire
·
May 18

Loews Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
May 15

Press Release: Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
May 14